Drug details

Elepsia XR (levetiracetam extended-release tablets)

type of Ligands

Elepsia XR (levetiracetam) Extended-release is an antiepileptic drug indicated as adjunctive therapy in the treatment of partial onset seizures in patients ≥ 12 years of age with epilepsy.

The drug is often used to treat Epilepsy .

This drug may have the following side effects:

• nausea,
• loss of appetite,
• dizziness,
• headache,
• nervousness,
• weakness,
• cough,
• sore throat,
• mood changes,
• drowsiness,
• anxiety,
• depression,
• irritability,
• pain,
• infection,
• runny or stuffy nose,
• influenza,
• numbness and tingling,
• loss of balance and coordination,
• vertigo,
• amnesia,
• sinus infection, and
• double vision.

The following drugs are related to Elepsia XR, either as a replacement or used together:

• Tegretol (carbamazepine)
• Cerebyx (fosphenytoin sodium injection)
• Onfi (clobazam tablets and oral suspension)
• Depacon (valproic acid)
• Depakene (valproic acid)
• Depakote ER (divalproex sodium)
• Depakote Sprinkle Capsules (divalproex sodium sprinkle capsules)
• Dilantin (phenytoin)
• Dilantin 125 (phenytoin oral suspension)
• Dilantin Infatabs (phenytoin tablets)
• Dilantin Kapseals (extended phenytoin sodium capsules)
• Zarontin (ethosuximide)
• Zarontin Oral Solution (ethosuximide oral solution)
• Felbatol (felbamate)
• Fycompa (perampanel tablets, for oral use)
• Gabitril (tiagabine hydrochloride)
• Topamax (topiramate)